Ruth Travis is a postdoctoral epidemiologist, having obtained her DPhil in cancer epidemiology at the University of Oxford in 2005. She is interested in examining the genetic and hormonal determinants of cancer, with a particular interest in breast and prostate cancer. Ruth has also published research on the association of melatonin in relation to breast cancer risk and is lead investigator for a study of the effects of shift work and circadian rhythms on cancer, funded by the Health and Safety Executive. Ruth is involved in several working groups within EPIC-Europe, including the EPIC-prostate and EPIC-lymphoma working groups, and represents EPIC as a member of the international Breast and Prostate Cancer Cohort Consortium (BPC3).
Posted Jul 29, 10:05 AM · link to this article